Furthermore, SLE studies from different laboratories have identified a relatively consistent phenotype, although FcRL4 expression is less clear, the CD21–/low MBCs that associate with disease manifestations are CD27–CD38lowCD11c+CXCR5–FcRL5+Tbethi. This evidence concerns the gene CXCR5 and systemic lupus erythematosus.